You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

bevacizumab-IRdye

Showing 1 - 25 of 2,189
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thyroid Carcinoma, Surgery Trial in Groningen (Bevacizumab-IRDye800CW)

Enrolling by invitation
  • Thyroid Carcinoma
  • Surgery
  • Groningen, Netherlands
    University Medical Center Groningen
Oct 18, 2023

Age-Related Macular Degeneration Trial (Bevacizumab-IRDye800CW, Vedolizumab-IRDye800CW)

Not yet recruiting
  • Age-Related Macular Degeneration
  • (no location specified)
May 19, 2022

Breast Cancer Trial (Bevacizumab-IRDye800CW)

Withdrawn
  • Breast Cancer
  • (no location specified)
Apr 28, 2022

Breast Cancer, Breast Cancer Invasive Trial in Groningen (Fluorescence guided detection of tumor positive margins.)

Not yet recruiting
  • Breast Cancer
  • Breast Cancer Invasive
  • Fluorescence guided detection of tumor positive margins.
  • Groningen, Netherlands
  • +1 more
Jul 10, 2023

Esophageal Cancer Trial in Groningen (Bevacizumab-IRDye800CW, Molecular Fluorescence Endoscopy platform)

Recruiting
  • Esophageal Cancer
  • Groningen, Netherlands
    University Medical Center Groningen
May 19, 2022

Hilar Cholangiocarcinoma Trial in Groningen (Bevacizumab-IRDye800CW, near infrared (NIR) fluorescence imaging)

Recruiting
  • Hilar Cholangiocarcinoma
  • Groningen, Netherlands
    University Medical Center Groningen
Apr 27, 2021

Pituitary Tumor, Pituitary Adenoma, Pituitary Macroadenoma Trial in Groningen (Bevacizumab-IRDye800CW, Molecular Fluorescence

Recruiting
  • Pituitary Tumor
  • +2 more
  • Groningen, Netherlands
    University Medical Center Groningen
Aug 31, 2021

Inverted Papilloma, Molecular Fluorescence Imaging Trial in Groningen (Bevacizumab-800CW)

Active, not recruiting
  • Inverted Papilloma
  • Molecular Fluorescence Imaging
  • Groningen, Netherlands
    University Medical Center Groningen
Apr 30, 2021

Barrett Esophagus Trial in Groningen (Bevacizumab-IRDye800CW, Fluorescence endoscopy)

Recruiting
  • Barrett Esophagus
  • Groningen, Netherlands
    University Medical Center Groningen
Nov 3, 2020

Soft Tissue Sarcoma Trial in Groningen (Bevacizumab-IRDye800CW)

Completed
  • Soft Tissue Sarcoma
  • Groningen, Netherlands
    University Medical Center Groningen
Jan 27, 2020

Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Groningen, Leiden, Nijmegen (Bevacizumab-800CW)

Terminated
  • Pancreatic Cancer
  • Pancreatic Adenocarcinoma
  • Groningen, Netherlands
  • +2 more
Jan 25, 2020

Colorectal Cancer Trial (Characterization of tumor tissue by fluorescence)

Withdrawn
  • Colorectal Cancer
  • Characterization of tumor tissue by fluorescence
  • (no location specified)
Mar 28, 2022

Colorectal Tumors, Colon Tumor, Sentinel Lymph Node Trial (Sentinel lymph node detection using intravenous bevacizumab-800CW)

Not yet recruiting
  • Colorectal Neoplasms
  • +3 more
  • Sentinel lymph node detection using intravenous bevacizumab-800CW
  • (no location specified)
Aug 10, 2022

Colonic Tumors, Sentinel Lymph Node, Fluorescence Trial (Sentinel lymph node identification)

Not yet recruiting
  • Colonic Neoplasms
  • +3 more
  • Sentinel lymph node identification
  • (no location specified)
Aug 10, 2022

Head and Neck Squamous Cell Carcinoma, Margin Assessment Trial in Groningen (Cetuximab-IRDye800CW)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Margin Assessment
  • Groningen, Netherlands
    University Medical Center Groningen
Apr 30, 2021

Hepatocellular Carcinoma Trial in Guangzhou (Candonilimab, Bevacizumab)

Withdrawn
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Jun 1, 2023

Patients With HHT. Follow up BABH

Completed
  • Hemorrhagic Hereditary Telangiectasia
  • HHT
  • bevacizumab treatment
  • Angers, France
  • +2 more
Sep 8, 2023

Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatocellular Carcinoma Non-resectable Trial in Seoul (Atezolizumab plus

Recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Atezolizumab plus bevacizumab, combined EBRT to vascular invasion
  • Atezolizumab plus bevacizumab
  • Seoul, Korea, Republic of
    Asan Medical Center
Aug 7, 2023

Brain Metastases Trial (Gamma Tile-Surgically Targeted Radiation Therapy (STaRT), Stereotactic Radiation Therapy)

Not yet recruiting
  • Brain Metastases
  • Gamma Tile-Surgically Targeted Radiation Therapy (STaRT)
  • Stereotactic Radiation Therapy
  • (no location specified)
Jun 2, 2023

Hepatocellular Carcinoma Trial in Guangzhou (Candonilimab, Bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Feb 26, 2023

Hepatocellular Carcinoma Trial in Nanjing, Shanghai (QL1706, Bevacizumab, Oxaliplatin injection)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Nanjing, Jiangsu, China
  • +1 more
Jul 28, 2023

Glioblastoma Trial (plasma collection)

Not yet recruiting
  • Glioblastoma
  • plasma collection
  • (no location specified)
Aug 18, 2023

Ovarian Cancer, Carcinoma, Ovarian Epithelial, Fallopian Tube Tumors Trial in Worldwide (biological, drug, other)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Pembrolizumab
  • +4 more
  • Phoenix, Arizona
  • +178 more
Jan 25, 2023

89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

Recruiting
  • Neurofibromatosis 2
  • Bevacizumab Zirconium Zr-89
  • Leiden, Zuid-Holland, Netherlands
    Leiden University Medical Center
Jan 5, 2023

Colorectal Cancer Trial (HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab, HR070803 simulator plus oxaliplatin, 5-FU/LV,

Not yet recruiting
  • Colorectal Cancer
  • HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab
  • HR070803 simulator plus oxaliplatin, 5-FU/LV, bevacizumab
  • (no location specified)
Jul 13, 2023